| Literature DB >> 24304547 |
Perri Zeitz Ruckart1, Frank J Bove, Morris Maslia.
Abstract
BACKGROUND: Drinking water supplies at Marine Corps Base Camp Lejeune were contaminated with trichloroethylene, tetrachloroethylene, benzene, vinyl chloride and trans-1,2-dichloroethylene during 1968 through 1985.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24304547 PMCID: PMC3880212 DOI: 10.1186/1476-069X-12-104
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Frequency of outcomes of specific birth defects and childhood cancers, Camp Lejeune, 1968–1985
| 17 | 15 | -- | 15 | 100.0 | |
| - anencephaly | 7 | 6 | 40.0 | 6 | 100.0 |
| - spina bifida | 10 | 9 | 60.0 | 9 | 100.0 |
| 27 | 24 | -- | 23 | 95.8 | |
| - cleft palate | 12 | 11 | 45.8 | 10 | 91.0 |
| - cleft lip (with or without cleft palate) | 15 | 13 | 54.2 | 13 | 100.0 |
| 14 | 13 | -- | 13 | 100.0 | |
| - leukemia | 11 | 11 | 84.6 | 11 | 100.0 |
| - non-Hodgkin’s lymphoma | 3 | 2 | 15.4 | 2 | 100.0 |
| 58 | 52 | -- | 51 | 98.1 | |
Risk factors for specific birth defects and childhood cancers, Camp Lejeune, 1968–1985
| Maternal age | | | | | | | |
| <20 | 86 (16.4) | 5 (33.3) | 2.6 (0.9, 7.6) | 4 (16.7) | 1.0 (0.3, 3.1) | 2 (15.4) | 0.9 (0.2, 4.3) |
| ≥20 | 438 (83.6) | 10 (66.7) | 1.0 (ref.) | 20 (83.3) | 1.0 (ref.) | 11 (84.6) | 1.0 (ref.) |
| Maternal education | | | | | | | |
| Not a college graduate | 375 (72.1) | 10 (66.7) | 0.8 (0.3, 2.3) | 19 (82.6) | 1.8 (0.6, 5.5) | 12 (92.3) | 4.6 (0.6, 36.0) |
| College graduate | 145 (27.9) | 5 (33.3) | 1.0 (ref.) | 4 (17.4) | 1.0 (ref.) | 1 (7.7) | 1.0 (ref.) |
| Prenatal Care† | | | | | | | |
| “Inadequate” | 44 (9.2) | 1 (6.7) | 0.7 (0.1, 5.5) | 2 (9.1) | 1.0 (0.2, 4.4) | 1 (8.3) | 0.9 (0.1, 7.1) |
| “Adequate” | 436 (90.8) | 14 (93.3) | 1.0 (ref.) | 20 (90.9) | 1.0 (ref.) | 11 (91.7) | 1.0 (ref.) |
| Prenatal vitamins, 1st trimester | | | | | | | |
| No | 64 (14.9) | 2 (13.3) | 0.9 (0.2, 4.0) | 4 (18.2) | 1.3 (0.4, 3.9) | 1 (8.3) | 0.5 (0.1, 4.1) |
| Yes | 365 (85.1) | 13 (86.7) | 1.0 (ref.) | 18 (81.8) | 1.0 (ref.) | 11 (91.7) | 1.0 (ref.) |
| 1st pregnancy | 168 (32.4) | 7 (46.7) | 1.8 (0.7, 5.1) | 12 (52.2) | 2.3 (1.0, 5.3) | 1 (8.3) | 0.2 (0.0, 1.5) |
| >1 pregnancy | 351 (67.6) | 8 (53.3) | 1.0 (ref.) | 11 (47.8) | 1.0 (ref.) | 11 (91.7) | 1.0 (ref.) |
| Mother worked, 1st trimester | | | | | | | |
| Yes | 76 (15.3) | 1 (7.7) | 0.5 (0.1, 3.6) | 5 (25.0) | 1.9 (0.7, 5.2) | 2 (15.4) | 1.0 (0.2, 4.6) |
| No | 421 (84.7) | 12 (92.3) | 1.0 (ref.) | 15 (75.0) | 1.0 (ref.) | 11 (84.6) | 1.0 (ref.) |
| Smoking, 1st trimester | | | | | | | |
| Yes | 130 (29.3) | 1 (6.7) | 0.2 (0.0, 1.3) | 4 (18.2) | 0.5 (0.2, 1.6) | 5 (41.7) | 1.7 (0.5, 5.5) |
| No | 314 (70.7) | 14 (93.3) | 1.0 (ref.) | 18 (81.8) | 1.0 (ref.) | 7 (58.3) | 1.0 (ref.) |
| Alcohol, 1st trimester | | | | | | | |
| Yes | 96 (21.7) | 3 (21.4) | 1.0 (0.3, 3.6) | 7 (31.8) | 1.7 (0.7, 4.3) | 1 (8.3) | 0.3 (0.0, 2.6) |
| No | 347 (78.3) | 11 (78.6) | 1.0 (ref.) | 15 (68.2) | 1.0 (ref.) | 11 (91.7) | 1.0 (ref.) |
| Fevers, 1st trimester | | | | | | | |
| Yes | 45 (10.7) | 1 (6.7) | 0.6 (0.1, 4.6) | 3 (13.6) | 1.3 (0.4, 4.6) | 2 (18.2) | 1.9 (0.4, 8.9) |
| No | 376 (89.3) | 14 (93.3) | 1.0 (ref.) | 19 (86.4) | 1.0 (ref.) | 9 (81.8) | 1.0 (ref.) |
| Passive smoke, 1st trimester | | | | | | | |
| Yes | 203 (45.9) | 5 (33.3) | 0.6 (0.2, 1.8) | 6 (27.3) | 0.4 (0.2, 1.2) | 7 (58.3) | 1.7 (0.5, 5.3) |
| No | 239 (54.1) | 10 (66.7) | 1.0 (ref.) | 16 (72.7) | 1.0 (ref.) | 5 (41.7) | 1.0 (ref.) |
| Child’s sex | | | | | | | |
| Male | 274 (52.1) | 6 (40.0) | 0.6 (0.2, 1.8) | 9 (37.5) | 0.6 (0.2, 1.3) | 8 (61.5) | 1.5 (0.5, 4.6) |
| Female | 252 (47.9) | 9 (60.0) | 1.0 (ref.) | 15 (67.5) | 1.0 (ref.) | 5 (38.5) | 1.0 (ref.) |
| Child’s race | | | | | | | |
| Non-white | 131 (25.0) | 1 (6.7) | 0.2 (0.0,1.6) | 6 (25.0) | 1.0 (0.4, 2.6) | 5 (38.5) | 1.9 (0.6-5.8) |
| “White” | 393 (75.0) | 14 (93.3) | 1.0 (ref.) | 18 (75.0) | 1.0 (ref.) | 8 (61.5) | 1.0 (ref.) |
| Child’s sibling has birth defect | | | | | | | |
| Yes | 45 (11.0) | 2 (14.3) | 1.3 (0.3, 6.2) | 6 (27.3) | 3.0 (1.1, 8.2) | 3 (27.3) | 3.0 (0.8, 11.8) |
| No | 364 (89.0) | 12 (85.7) | 1.0 (ref.) | 16 (72.7) | 1.0 (ref.) | 8 (72.7) | 1.0 (ref.) |
| Dad smoked † † | | | | | | | |
| Yes | 273 (52.6) | 6 (40.0) | 0.6 (0.2, 1.7) | 8 (36.4) | 0.5 (0.2, 1.3) | 9 (69.2) | 2.0 (0.6, 6.7) |
| No | 246 (47.4) | 9 (60.0) | 1.0 (ref.) | 14 (63.6) | 1.0 (ref.) | 4 (30.8) | 1.0 (ref.) |
| Dad possibly exposed to Agent Orange | | | | | | | |
| Yes | 158 (31.2) | 3 (20.0) | 0.6 (0.2, 2.0) | 6 (26.1) | 0.8 (0.3, 2.0) | 5 (38.5) | 1.4 (0.4, 4.3) |
| No | 348 (68.8) | 12 (80.0) | 1.0 (ref.) | 17 (73.9) | 1.0 (ref.) | 8 (61.5) | 1.0 (ref.) |
| Dad occupationally exposed to solvents § | | | | | | | |
| Yes | 167 (32.5) | 6 (40.0) | 1.4 (0.5-3.9) | 6 (26.1) | 0.7 (0.3-1.9) | 4 (30.8) | 0.9 (0.3-3.0) |
| No | 347 (67.5) | 9 (60.0) | 1.0 (ref.) | 17 (73.9) | 1.0 (ref.) | 9 (69.2) | 1.0 (ref.) |
*one control series for all case groups.
** childhood leukemia and childhood non-Hodgkin’s lymphoma.
† “Adequate”: prenatal care began during 1st trimester; “Inadequate”: prenatal care began later in pregnancy or no care was received.
† † During the three months before conception.
§ During the six months before conception.
Mother’s water consumption habits during the first trimester of pregnancy, Camp Lejeune, 1968–1985
| Daily average glasses of tap water | | | | | | | | |
| ≤5 | 256 | 49.7 | 4 | 26.7 | 9 | 39.1 | 2 | 15.4 |
| >5 | 259 | 50.3 | 11 | 73.3 | 14 | 60.9 | 11 | 84.6 |
| Frequency mother showered or bathed | | | | | | | | |
| ≤7/week | 390 | 74.1 | 11 | 73.3 | 17 | 70.8 | 9 | 69.2 |
| 8 – 13/week | 43 | 8.2 | 1 | 6.7 | 3 | 12.5 | 0 | 0.0 |
| ≥14/week | 93 | 17.7 | 3 | 20.0 | 4 | 16.7 | 4 | 30.8 |
*childhood leukemia and childhood non-Hodgkin’s lymphoma.
Neural tube defects and average VOC exposure*, first trimester, Camp Lejeune, 1968–1985
| | ||||
|---|---|---|---|---|
| | | | ||
| Unexposed | 330 (62.7) | 10 (66.7) | 1.0 (ref.) | |
| Below MCL (>0- ≤ 5 ppb) | 27 (5.1) | 3 (20.0) | 3.7 (1.0-14.1) | 0.06 |
| Above MCL (> 5 ppb) | 169 (32.1) | 2 (13.3) | 0.4 (0.1- 1.8) | 0.23 |
| Unexposed | 330 (62.7) | 10 (66.7) | 1.0 (ref.) | |
| Exposed | 196 (37.2) | 5 (33.3) | 0.8 (0.3-2.5) | 0.76 |
| | | | ||
| Unexposed | 287 (54.6) | 7 (46.7) | 1.0 (ref.) | |
| Low (>0- ≤ 2 ppb) | 114 (21.7) | 4 (26.7) | 1.4 (0.4-5.0) | 0.57 |
| High (> 2 ppb) | 125 (23.8) | 4 (26.7) | 1.3 (0.4-4.6) | 0.67 |
| Unexposed | 287 (54.6) | 7 (46.7) | 1.0 (ref.) | |
| Below MCL (>0- ≤ 5 ppb) | 188 (35.7) | 5 (33.3) | 1.1 (0.3-3.5) | 0.88 |
| Above MCL (>5 ppb) | 51 (9.7) | 3 (20.0) | 2.4 (0.6-9.6) | 0.21 |
| Unexposed | 287 (54.6) | 7 (46.7) | 1.0 (ref.) | |
| Exposed | 239 (45.4) | 8 (53.3) | 1.4 (0.5-3.8) | 0.55 |
| | | | ||
| Unexposed | 453 (86.1) | 9 (60.0) | 1.0 (ref.) | |
| Exposed | 73 (13.9) | 6 (40.0) | 4.1 (1.4-12.0) | 0.01 |
| | | | ||
| Unexposed | 329 (62.5) | 9 (60.0) | 1.0 (ref.) | |
| Exposed | 197 (37.5) | 6 (40.0) | 1.1 (0.4-3.2) | 0.84 |
| | | | ||
| Unexposed | 328 (62.4) | 9 (60.0) | 1.0 (ref.) | |
| Exposed | 198 (37.6) | 6 (40.0) | 1.1 (0.4-3.1) | 0.85 |
*when possible, we divided the exposed group by the 50th percentile level among controls (low and high); we excluded categorizations where there were <2 exposed cases in a cell.
Oral cleft defects and average VOC exposure*, first trimester, Camp Lejeune, 1968–1985
| | ||||
|---|---|---|---|---|
| | | | ||
| Unexposed | 304 (57.8) | 17 (70.8) | 1.0 (ref.) | |
| Low (>0- < 44 ppb) | 111 (21.1) | 4 (16.7) | 0.6 (0.2-2.0) | 0.43 |
| High (≥ 44 ppb) | 111 (21.1) | 3 (12.5) | 0.5 (0.1-1.7) | 0.25 |
| Unexposed | 304 (57.8) | 17 (70.8) | 1.0 (ref.) | |
| Below MCL (>0- ≤ 5 ppb) | 37 (7.0) | 2 (8.3) | 1.0 (0.2-4.4) | 0.96 |
| Above MCL (> 5 ppb) | 185 (35.2) | 5 (20.8) | 0.5 (0.2-1.3) | 0.16 |
| Unexposed | 304 (57.8) | 17 (70.8) | 1.0 (ref.) | |
| Exposed | 222 (42.2) | 7 (29.2) | 0.6 (0.2-1.4) | 0.21 |
| | | | ||
| Unexposed | 253 (48.1) | 15 (62.5) | 1.0 (ref.) | |
| Low (>0- ≤ 2 ppb) | 130 (24.7) | 4 (16.7) | 0.5 (0.2-1.6) | 0.25 |
| High (> 2 ppb) | 143 (27.2) | 5 (20.8) | 0.6 (0.2-1.7) | 0.32 |
| Unexposed | 253 (48.1) | 15 (62.5) | 1.0 (ref.) | |
| Below MCL (>0- ≤ 5 ppb) | 212 (40.3) | 6 (25.0) | 0.5 (0.2-1.3) | 0.13 |
| Above MCL (>5 ppb) | 61 (11.6) | 3 (12.5) | 0.8 (0.2-3.0) | 0.77 |
| Unexposed | 253 (48.1) | 15 (62.5) | 1.0 (ref.) | |
| Exposed | 273 (51.9) | 9 (37.5) | 0.6 (0.2-1.3) | 0.17 |
| | | | ||
| Unexposed | 432 | 21 (87.5) | 1.0 (ref.) | |
| Exposed | 94 | 3 (12.5) | 0.7 (0.2-2.2) | 0.50 |
| | | | ||
| Unexposed | 301 (57.2) | 17 (70.8) | 1.0 (ref.) | |
| Low (>0- < 3 ppb) | 141 (26.8) | 4 (16.7) | 0.5 (0.2-1.5) | 0.22 |
| High (≥ 3 ppb) | 84 (16.0) | 3 (12.5) | 0.6 (0.2-2.2) | 0.47 |
| Unexposed | 301 (57.2) | 17 (70.8) | 1.0 (ref.) | |
| Below MCL (>0- ≤ 2 ppb) | 74 (14.1) | 4 (16.7) | 1.0 (0.3-3.0) | 0.94 |
| Above MCL (> 2 ppb) | 151 (28.7) | 3 (12.5) | 0.4 (0.1-1.2) | 0.10 |
| Unexposed | 301 (57.2) | 17 (70.8) | 1.0 (ref.) | |
| Exposed | 225 (42.8) | 7 (29.2) | 0.6 (0.2-1.4) | 0.19 |
| | | | ||
| Unexposed | 300 (57.0) | 17 (70.8) | 1.0 (ref.) | |
| Low (>0- < 5 ppb) | 116 (22.1) | 4 (16.7) | 0.6 (0.2-1.8) | 0.38 |
| High (≥ 5 ppb) | 110 (20.9) | 3 (12.5) | 0.5 (0.1-1.7) | 0.25 |
| Unexposed | 300 (57.0) | 17 (70.8) | 1.0 (ref.) | |
| Exposed | 226 (43.0) | 7 (29.2) | 0.5 (0.2-1.3) | 0.19 |
*when possible, we divided the exposed group by the 50th percentile level among controls (low and high); we excluded categorizations where there were <2 exposed cases in a cell.
Childhood cancers* and average VOC exposure**, first trimester, Camp Lejeune, 1968–1985
| | ||||
|---|---|---|---|---|
| | | | ||
| Unexposed | 304 (57.8) | 6 (46.2) | 1.0 (ref.) | |
| Low (>0- < 44 ppb) | 111 (21.1) | 4 (30.8) | 1.8 (0.5-6.6) | 0.36 |
| High (≥ 44 ppb) | 111 (21.1) | 3 (23.1) | 1.4 (0.3-5.6) | 0.66 |
| Unexposed | 304 (57.8) | 6 (46.2) | 1.0 (ref.) | |
| Exposed | 222 (42.2) | 7 (53.8) | 1.6 (0.5-4.8) | 0.41 |
| | | | ||
| Unexposed | 253 (48.1) | 6 (46.2) | 1.0 (ref.) | |
| Low (>0- ≤ 2 ppb) | 130 (24.7) | 5 (38.5) | 1.6 (0.5-5.4) | 0.43 |
| High (> 2 ppb) | 143 (27.2) | 2 (15.4) | 0.6 (0.1-3.0) | 0.52 |
| Unexposed | 253 (48.1) | 6 (46.2) | 1.0 (ref.) | |
| Exposed | 273 (51.9) | 7 (53.8) | 1.1 (0.4-3.3) | 0.89 |
| | | | ||
| Unexposed | 432 | 11 (84.6) | 1.0 (ref.) | |
| Exposed | 94 | 2 (15.4) | 0.8 (0.2-3.8) | 0.82 |
| | | | ||
| Unexposed | 301 (57.2) | 6 (46.2) | 1.0 (ref.) | |
| Low (>0- < 3 ppb) | 141 (26.8) | 5 (38.5) | 1.8 (0.5-6.0) | 0.35 |
| High (≥ 3 ppb) | 84 (16.0) | 2 (15.4) | 1.2 (0.2-6.0) | 0.83 |
| Unexposed | 301 (57.2) | 6 (46.2) | 1.0 (ref.) | |
| Below MCL (>0- ≤ 2 ppb) | 74 (14.1) | 3 (23.1) | 2.0 (0.5-8.3) | 0.32 |
| Above MCL (> 2 ppb) | 151 (28.7) | 4 (30.8) | 1.3 (0.4-4.8) | 0.66 |
| Unexposed | 301 (57.2) | 6 (46.2) | 1.0 (ref.) | |
| Exposed | 225 (42.8) | 7 (53.8) | 1.6 (0.5-4.7) | 0.43 |
| | | | ||
| Unexposed | 300 (57.0) | 6 (46.2) | 1.0 (ref.) | |
| Low (>0- < 5 ppb) | 116 (22.1) | 4 (30.8) | 1.7 (0.5-6.2) | 0.41 |
| High (≥ 5 ppb) | 110 (20.9) | 3 (23.1) | 1.4 (0.3-5.5) | 0.66 |
| Unexposed | 300 (57.0) | 6 (46.2) | 1.0 (ref.) | |
| Exposed | 226 (43.0) | 7 (53.8) | 1.5 (0.5-4.7) | 0.44 |
*childhood leukemia and childhood non-Hodgkin’s lymphoma.
**when possible, we divided the exposed group by the 50th percentile level among controls (low and high); we excluded categorizations where there were <2 exposed cases in a cell.